Page last updated: 2024-12-06
cyclohexaneacetic acid
Description
Cyclohexaneacetic acid, also known as 2-(cyclohexyl)acetic acid, is a cyclic organic compound with the formula C8H14O2. It is a colorless liquid with a pungent odor. Cyclohexaneacetic acid is a versatile building block in organic synthesis and can be used to produce a variety of other compounds, including pharmaceuticals and pesticides. It is also a common component of fragrances and flavorings. Cyclohexaneacetic acid can be synthesized through various methods, including the reaction of cyclohexanone with ethyl acetate followed by hydrolysis, and the reaction of cyclohexyl bromide with sodium cyanide followed by hydrolysis. Cyclohexaneacetic acid has been shown to exhibit biological activity, including anti-inflammatory and analgesic properties. However, it is not typically used as a therapeutic agent due to its toxicity. Cyclohexaneacetic acid is an important compound in the study of organic chemistry, as it serves as a model system for understanding the reactivity and properties of cyclic compounds. Its synthesis and reactivity have been extensively studied, and it has been used to develop new synthetic methods and to investigate the mechanisms of various chemical reactions.'
cyclohexylacetic acid : A monocarboxylic acid consisting of cyclohexane carrying a carboxymethyl substituent. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]
Cross-References
ID Source | ID |
PubMed CID | 21363 |
CHEBI ID | 37277 |
SCHEMBL ID | 175425 |
MeSH ID | M0070866 |
Synonyms (52)
Synonym |
5292-21-7 |
cyclohexaneacetic acid |
nsc-2159 |
cyclohexylacetic acid |
wln: l6tj a1vq |
cyclohexylethanoic acid |
nsc2159 |
einecs 226-132-0 |
ai3-14243 |
fema no. 2347 |
brn 2041326 |
hexahydrophenylacetic acid |
nsc 2159 |
CHEBI:37277 |
2-cyclohexylacetic acid |
cyclohexane-acetic acid |
cyclohexaneacetic acid, >=99% |
cyclohexaneacetic acid, >=98% |
NCIOPEN2_009320 |
inchi=1/c8h14o2/c9-8(10)6-7-4-2-1-3-5-7/h7h,1-6h2,(h,9,10) |
ljoodbdwmqkmfb-uhfffaoysa- |
AKOS000120683 |
2-cyclohexyl-acetic acid |
A829309 |
STL168028 |
unii-v43k3to0hn |
v43k3to0hn , |
FT-0607679 |
S6022 |
cyclohexane acetic acid |
cyclohexyl acetic acid |
cyclohexane acetic acid [fhfi] |
cyclohexyl-acetic acid |
cyclo-hexylacetic acid |
SCHEMBL175425 |
DTXSID7063762 |
J-520168 |
F2191-0072 |
mfcd00001518 |
GS-3062 |
fema 2347 |
F11130 |
CS-W019439 |
Q27117096 |
4-bromo-oxindole |
BCP30886 |
EN300-21004 |
AMY31936 |
cyclohexyacetic acid |
HY-W018653 |
SY001139 |
Z104486044 |
Drug Classes (1)
Class | Description |
monocarboxylic acid | An oxoacid containing a single carboxy group. |
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] |
Research
Studies (9)
Timeframe | Studies, This Drug (%) | All Drugs % |
pre-1990 | 3 (33.33) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (11.11) | 29.6817 |
2010's | 4 (44.44) | 24.3611 |
2020's | 1 (11.11) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 30.59
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
Metric | This Compound (vs All) |
---|
Research Demand Index | 30.59 (24.57) | Research Supply Index | 2.30 (2.92) | Research Growth Index | 5.03 (4.65) | Search Engine Demand Index | 29.80 (26.88) | Search Engine Supply Index | 2.00 (0.95) |
| |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 9 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |